Logo
Vista

Refine Clinical Development Strategies

Access a multi-indication oncology dataset based on EMR data that offers comprehensive insights into the full range of oncological diseases, revealing unmet epidemiological needs and providing a holistic understanding of patient journeys at scale.

Group 46
Use Cases

Track Holistic Patient Journeys at Scale

Vista allows life sciences to holistically track the journeys of real oncology patients across the disease spectrum. The inclusion of non-oncological data enables further identification of epidemiological trends and guidance of research decisions.

Automated Updates and Data Standardization

Vista uses structured EMR data and machine learning to standardize patient data across disease states and treatment protocols for easy comparative analysis.

Designed for Large-Scale Biopharmaceutical Research

Vista is continuously being improved and enriched with data and clinical logic through collaboration with biopharma partners.

Group 202

COTA by the Numbers

2.1M+ Cancer Patient Lives

50/50 Academic vs. Community Treatment Setting

3 Approvals Supported

9 Hematology and Solid Tumor Diagnoses

5-Year Average Follow-up

2X Higher Inclusion Percentage in ECA vs. Competitor

Group 203
Additional Support

Get the Most of Your Vista Data with Real-World Insights and Support

Real-World Insights and Support is an optional add-on that pairs perfectly with your Vista data. Our team of clinical experts, researchers, and statisticians will come alongside your teams to help them use the data to design studies, run analyses, and construct regulatory submission packages.

Resources

Fueling the Future of Cancer Research

Explore our collection of clinical research, recent press, podcasts, and more.

RWD and GenAI: How technology’s new power couple will revolutionize life sciences

Generative AI (GenAI) is quickly proving itself to be one of the most transformative technologies of our time with its...

COTA and Texas Oncology Collaborate to Advance AI-Enabled Precision Medicine

New York — COTA, Inc., in collaboration with Texas Oncology’s Precision Health Informatics, LLC (PHI), announces an innovative collaboration aimed at...

Who, what, when…and especially where: Why care settings matter for representative real-world datasets

A vast majority of cancer patients’ care starts with a visit to a primary care provider for a routine screening...

See the Bigger Picture of Oncology

Discover the power of real-world cancer data to help you understand patient journeys across the oncology spectrum and inform research directions.

Group 11